HK1246350B - 胱硫醚β-合酶的純化 - Google Patents

胱硫醚β-合酶的純化

Info

Publication number
HK1246350B
HK1246350B HK18105730.4A HK18105730A HK1246350B HK 1246350 B HK1246350 B HK 1246350B HK 18105730 A HK18105730 A HK 18105730A HK 1246350 B HK1246350 B HK 1246350B
Authority
HK
Hong Kong
Prior art keywords
synthase
purification
cystathionine beta
cystathionine
beta
Prior art date
Application number
HK18105730.4A
Other languages
English (en)
Inventor
Richard G Carrillo
Jan P Kraus
Tomas Majtan
David Naveh
Original Assignee
Univ Colorado Regents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Colorado Regents filed Critical Univ Colorado Regents
Publication of HK1246350B publication Critical patent/HK1246350B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin or biotin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/01—Hydro-lyases (4.2.1)
    • C12Y402/01022—Cystathionine beta-synthase (4.2.1.22)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK18105730.4A 2012-03-26 2018-05-03 胱硫醚β-合酶的純化 HK1246350B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615629P 2012-03-26 2012-03-26
US13/830,494 US9243239B2 (en) 2012-03-26 2013-03-14 Purification of cystathionine beta-synthase

Publications (1)

Publication Number Publication Date
HK1246350B true HK1246350B (zh) 2020-05-15

Family

ID=49212017

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18105730.4A HK1246350B (zh) 2012-03-26 2018-05-03 胱硫醚β-合酶的純化

Country Status (11)

Country Link
US (4) US9243239B2 (zh)
EP (3) EP2831229B8 (zh)
JP (3) JP6146934B2 (zh)
CN (1) CN104540940B (zh)
AU (1) AU2013240003B2 (zh)
BR (1) BR112014023570B1 (zh)
CA (1) CA2867719C (zh)
HK (1) HK1246350B (zh)
IL (2) IL234635B (zh)
IN (1) IN2014DN07920A (zh)
WO (1) WO2013148580A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034318B2 (en) 2011-08-30 2015-05-19 The Regents Of The University Of Colorado, A Body Corporate Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
US9243239B2 (en) * 2012-03-26 2016-01-26 The Regents Of The University Of Colorado, A Body Corporate Purification of cystathionine beta-synthase
US9675678B2 (en) 2013-01-29 2017-06-13 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
PL3373922T3 (pl) 2015-11-09 2022-05-02 The Regents Of The University Of Colorado, A Body Corporate Kompozycje i sposoby do stosowania do leczenia homocystynurii
JP7146897B2 (ja) 2017-04-17 2022-10-04 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイト ホモシスチン尿症の治療のための酵素補充療法の最適化
US20220315965A1 (en) * 2019-06-25 2022-10-06 Zymergen Inc. Engineered biosynthetic pathways for production of cystathionine by fermentation
JP2022539077A (ja) * 2019-06-26 2022-09-07 トラヴェール セラピューティクス スウィツァランド ゲーエムベーハー ホモシスチン尿症を処置するための酵素療法のためのｐｅｇ化シスタチオニンベータ合成酵素

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5576559A (en) 1978-12-01 1980-06-09 Chiyou Lsi Gijutsu Kenkyu Kumiai Electron beam fine adjusting device
US5523225A (en) 1993-09-13 1996-06-04 Regents Of The University Of Colorado DNA sequence encoding human cystathionine β-synthase
US5635375A (en) 1995-01-09 1997-06-03 Regents Of The University Of Colorado Method of increasing the yield and heme saturation of cystathione β-synthase
AU2003251550A1 (en) 2002-06-17 2003-12-31 The Regents Of The University Of Colorado HUMAN CYSTATHIONINE Beta-SYNTHASE VARIANTS AND METHODS OF PRODU CTION THEREOF
GB0216001D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
EP1396537A1 (en) 2002-09-04 2004-03-10 Avidis SA Treatment of elevated plasma homocysteine
CN1552905A (zh) * 2003-12-18 2004-12-08 中国农业科学院茶叶研究所 一类茶树胱硫醚-γ-合成酶特异表达序列标签及其生物芯片
EP1878739A1 (en) 2006-07-14 2008-01-16 LEK Pharmaceuticals D.D. One step IMAC (MCAC) purification of proteins
KR101914023B1 (ko) 2010-02-04 2018-11-01 아에메이즈, 인코포레이티드 메티오닌-감마-라이아제 효소를 이용하여 유전자조작된 효소 및 이의 약리학적 제제
US9243239B2 (en) 2012-03-26 2016-01-26 The Regents Of The University Of Colorado, A Body Corporate Purification of cystathionine beta-synthase

Also Published As

Publication number Publication date
IL234635B (en) 2018-12-31
EP2831229B1 (en) 2017-10-18
EP3263701A1 (en) 2018-01-03
IL263162A (en) 2018-12-31
US10160962B2 (en) 2018-12-25
BR112014023570A2 (pt) 2021-06-01
JP6146934B2 (ja) 2017-06-21
EP2831229A1 (en) 2015-02-04
US20200131497A1 (en) 2020-04-30
JP2015512639A (ja) 2015-04-30
JP6952361B2 (ja) 2021-10-20
AU2013240003B2 (en) 2018-04-19
IL263162B (en) 2019-11-28
WO2013148580A1 (en) 2013-10-03
JP6839595B2 (ja) 2021-03-10
AU2013240003A1 (en) 2014-10-02
JP2020000259A (ja) 2020-01-09
IN2014DN07920A (zh) 2015-05-01
JP2017121255A (ja) 2017-07-13
US10941392B2 (en) 2021-03-09
US20190055537A1 (en) 2019-02-21
BR112014023570B1 (pt) 2022-03-15
CN104540940A (zh) 2015-04-22
CA2867719C (en) 2020-08-11
EP3263701B1 (en) 2019-06-19
US9243239B2 (en) 2016-01-26
EP3569706A1 (en) 2019-11-20
US20160177287A1 (en) 2016-06-23
EP2831229B8 (en) 2018-10-17
US20130251700A1 (en) 2013-09-26
CN104540940B (zh) 2018-03-06
CA2867719A1 (en) 2013-10-03

Similar Documents

Publication Publication Date Title
IL287057A (en) Purified iduronate-2-sulfatase
HK1213899A1 (zh) 抑制 蛋白的二氫吡啶並吡嗪酮
HK1211033A1 (zh) 蛋白抑制劑二氫喹喔啉酮
HK1204797A1 (zh) 新穎的抗- 抗體
IL263162B (en) Purification of cystathionine beta-synthase
ZA201406082B (en) Use of ccr3-inhibitors
EP2917314A4 (en) OLIGOMERATZUSAMMENSETZUNG
SG10201510800PA (en) Purification of flaviviruses
IL236312A0 (en) Preparation of 18f-flucyclobin
SG11201406800UA (en) Purification of air
GB201209082D0 (en) Purification method
PL2832243T3 (pl) Odcięty fragment arkusza zawierającego zapach
HRP20150833T1 (en) Water-power of screw type
HK1206717A1 (zh) 作爲β-澱粉樣蛋白抑制劑的吲哚-酰胺化合物
GB2507762B (en) Improvements to dartboards
AU5382P (en) HI01 Pittosporum tenuifolium
GB201203494D0 (en) Hydrophobin purification
TWM433525U (en) Structure of calorifier
GB201204173D0 (en) Water purification
EP2814499A4 (en) PURIFICATION PROCESS
GB201201142D0 (en) Sdd